Antiseizure medications(ASM) | P-value | ||
---|---|---|---|
Monotherapy (n = 15)* | Polytherapy (n = 15) | ||
Psychometric tests | |||
IQ test | 100.2 ± 4.6 | 100.6 ± 3.8 | 0.8 |
DST | 6.9 ± 1.1 | 7.1 ± 0.92 | 0.6 |
WMS | 26.2 ± 5.02 | 27.3 ± 5.8 | 0.5 |
CDT | 24.5 ± 4.03 | 23.3 ± 3.9 | 0.4 |
Trail Making A | 39.5 ± 6.6 | 43 ± 8.2 | 0.2 |
Trail Making B | 104.8 ± 11.8 | 117.6 ± 14.5 | 0.01* |
COWAT-phenomic | 32.7 ± 4.5 | 35.7 ± 6.6 | 0.2 |
COWAT-semantic | 11.6 ± 1.7 | 12.1 ± 2.2 | 0.5 |
Radiological data | |||
NAA | 13.9 ± 3.9 | 13.3 ± 2.8 | 0.6 |
Choline | 2.3 ± 0.61 | 2.3 ± 0.51 | 0.7 |
Creatinine | 8.7 ± 2.7 | 8.1 ± 2.2 | 0.5 |
NAA/choline | 6.5 ± 2.4 | 6.3 ± 1.6 | 0.8 |
NAA/creat | 1.8 ± 0.76 | 1.7 ± 0.45 | 0.9 |
Choline/create | 0.29 ± 0.09 | 0.30 ± 0.12 | 0.8 |